Ausgabe 10/2019
Inhalt (25 Artikel)
PET and SPECT in psychiatry: the past and the future
Marco Pagani, Sara Carletto, Luca Ostacoli
Correction to: 225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study
Mike Sathekge, Frank Bruchertseifer, Otto Knoesen, Florette Reyneke, Ismaheel Lawal, Thabo Lengana, Cindy Davis, Johncy Mahapane, Ceceila Corbett, Mariza Vorster, Alfred Morgenstern
Correction to: Multiple cardiovascular involvements in Behçet’s disease: unique utility of 18F-FDG PET/CT in diagnosis and follow-up
Xiao-Ying Xi, Wei Gao, Xiao-Juan Guo, Wei Jiang, Yuan-Hua Yang, Juan-Ni Gong, Min-Fu Yang
Two decades of SPECT/CT – the coming of age of a technology: An updated review of literature evidence
Ora Israel, O. Pellet, L. Biassoni, D. De Palma, E. Estrada-Lobato, G. Gnanasegaran, T. Kuwert, C. la Fougère, G. Mariani, S. Massalha, D. Paez, F. Giammarile
18F FDG-PET/CT has poor diagnostic accuracy in diagnosing shoulder PJI
Thomas Falstie-Jensen, J. Lange, H. Daugaard, M. H. Vendelbo, A. K. Sørensen, B. Zerahn, J. Ovesen, K. Søballe, L. C. Gormsen, B. S. Olsen, H. V. S. Johanssen, B. Elmengaard, T. M. Thillemann, L. Bolvig
Synergistic application of pulmonary 18F-FDG PET/HRCT and computer-based CT analysis with conventional severity measures to refine current risk stratification in idiopathic pulmonary fibrosis (IPF)
Francesco Fraioli, Maria Lyasheva, Joanna C. Porter, Jamshed Bomanji, Robert I. Shortman, Raymond Endozo, Simon Wan, Linda Bertoletti, Maria Machado, Balaji Ganeshan, Thida Win, Ashley M. Groves
Heart rate reserve is a long-term risk predictor in women undergoing myocardial perfusion imaging
Caroline E. Gebhard, Monika Marędziak, Angela Portmann, Susan Bengs, Ahmed Haider, Michael Fiechter, Bernhard A. Herzog, Michael Messerli, Valerie Treyer, Ken Kudura, Elia von Felten, Dominik C. Benz, Tobias A. Fuchs, Christoph Gräni, Aju P. Pazhenkottil, Ronny R. Buechel, Philipp A. Kaufmann, Catherine Gebhard
Prospective diagnostic performance of semiconductor SPECT myocardial perfusion imaging: wall thickening analysis reduces the need for an additional prone acquisition
Loïc Djaileb, Benjamin Dubois, Nicolas de Leiris, Julien Leenhardt, Marjorie Canu, Olivier Phan Sy, Adrien Carabelli, Bastien Boussat, Laurent Dumas, Alexis Broisat, Gérald Vanzetto, Daniel Fagret, Catherine Ghezzi, Gilles Barone-Rochette, Laurent M. Riou
[11C]JNJ54173717, a novel P2X7 receptor radioligand as marker for neuroinflammation: human biodistribution, dosimetry, brain kinetic modelling and quantification of brain P2X7 receptors in patients with Parkinson’s disease and healthy volunteers
Donatienne Van Weehaeghe, Michel Koole, Mark E. Schmidt, Stephanie Deman, Andreas H. Jacobs, Erika Souche, Kim Serdons, Stefan Sunaert, Guy Bormans, Wim Vandenberghe, Koen Van Laere
Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson’s disease patients with impulse control disorders
I. Navalpotro-Gomez, R. Dacosta-Aguayo, F. Molinet-Dronda, A. Martin-Bastida, A. Botas-Peñin, H. Jimenez-Urbieta, M. Delgado-Alvarado, B. Gago, A. Quiroga-Varela, Maria C. Rodriguez-Oroz
[18F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer’s disease
Sandra Sanabria Bohórquez, Jan Marik, Annie Ogasawara, Jeff N. Tinianow, Herman S. Gill, Olivier Barret, Gilles Tamagnan, David Alagille, Gai Ayalon, Paul Manser, Thomas Bengtsson, Michael Ward, Simon-Peter Williams, Geoffrey A. Kerchner, John P. Seibyl, Kenneth Marek, Robby M. Weimer
Longitudinal cognitive decline in mild cognitive impairment subjects with early amyloid-β neocortical deposition
Andrea Ciarmiello, E. Giovannini, M. Riondato, G. Giovacchini, V. Duce, O. Ferrando, M. De Biasi, C. Passera, E. Carabelli, A. Mannironi, L. Mansi, A. Tartaglione
Evaluation of pharmacokinetic modeling strategies for in-vivo quantification of tau with the radiotracer [18F]MK6240 in human subjects
Nicolas J. Guehl, Dustin W. Wooten, Daniel L. Yokell, Sung-Hyun Moon, Maeva Dhaynaut, Samantha Katz, Kirsten A. Moody, Codi Gharagouzloo, Aurélie Kas, Keith A. Johnson, Georges El Fakhri, Marc D. Normandin
European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma
David Taïeb, Rodney J. Hicks, Elif Hindié, Benjamin A. Guillet, Anca Avram, Pietro Ghedini, Henri J. Timmers, Aaron T. Scott, Saeed Elojeimy, Domenico Rubello, Irène J. Virgolini, Stefano Fanti, Sona Balogova, Neeta Pandit-Taskar, Karel Pacak
Hybrid PET/MRI in major cancers: a scoping review
Anni Morsing, Malene Grubbe Hildebrandt, Mie Holm Vilstrup, Sara Elisabeth Wallenius, Oke Gerke, Henrik Petersen, Allan Johansen, Thomas Lund Andersen, Poul Flemming Høilund-Carlsen
68Ga-NOTA-Aca-BBN(7-14) PET imaging of GRPR in children with optic pathway glioma
Jingjing Zhang, Yongji Tian, Deling Li, Gang Niu, Lixin Lang, Fang Li, Yuhan Liu, Zhaohui Zhu, Xiaoyuan Chen
18F-Fluoroethyl-tyrosine uptake is correlated with amino acid transport and neovascularization in treatment-naive glioblastomas
Friederike Liesche, Mathias Lukas, Christine Preibisch, Kuangyu Shi, Jürgen Schlegel, Bernhard Meyer, Markus Schwaiger, Claus Zimmer, Stefan Förster, Jens Gempt, Thomas Pyka
Prospective evaluation of the performance of [68Ga]Ga-PSMA-11 PET/CT(MRI) for lymph node staging in patients undergoing superextended salvage lymph node dissection after radical prostatectomy
Mohammad Abufaraj, Bernhard Grubmüller, Markus Zeitlinger, Gero Kramer, Christian Seitz, Andrea Haitel, Pascal Baltzer, Marcus Hacker, Wolfgang Wadsak, Sarah Pfaff, Tomasz Wiatr, Markus Mitterhauser, Shahrokh F. Shariat, Markus Hartenbach
Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies
Heiko Kroth, Felix Oden, Jerome Molette, Hanno Schieferstein, Francesca Capotosti, Andre Mueller, Mathias Berndt, Heribert Schmitt-Willich, Vincent Darmency, Emanuele Gabellieri, Cédric Boudou, Tanja Juergens, Yvan Varisco, Efthymia Vokali, David T. Hickman, Gilles Tamagnan, Andrea Pfeifer, Ludger Dinkelborg, Andreas Muhs, Andrew Stephens
Influx rate of 18F-fluoroaminosuberic acid reflects cystine/glutamate antiporter expression in tumour xenografts
Kathinka E. Pitman, Santosh R. Alluri, Alexander Kristian, Eva-Katrine Aarnes, Heidi Lyng, Patrick J. Riss, Eirik Malinen
Evaluation of neurotensin receptor 1 as potential biomarker for prostate cancer theranostic use
Tingting He, Mengzhe Wang, Hui Wang, Hongpei Tan, Yongxiang Tang, Eric Smith, Zhanhong Wu, Weihua Liao, Shuo Hu, Zibo Li
Dual-phase 18F-FP-CIT PET in corticobasal syndrome underlying AD pathology
Jung Han Yoon, Young Sil Ahn
Multiple cardiovascular involvements in Behçet’s disease: unique utility of 18F-FDG PET/CT in diagnosis and follow-up
Xiao-Ying Xi, Wei Gao, Xiao-Juan Guo, Wei Jiang, Yuan-Hua Yang, Juan-Ni Gong, Min-Fu Yang
Exceptional 4-year response to 177Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer
Andrei Gafita, Hui Wang, Robert Tauber, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber